Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal Antioxidants for Cardiovascular Disease in Older African Americans
NCT00010725Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Sep 1999
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MAK Immune Cells in cardiovascular disease (CVD), sponsored by National Center for Complementary and Integrative Health. Started Sep 1999; status: completed.
02
Drugs
MAK Immune Cells
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00010725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010725.